ARX-001822

N/A

Report date: 2025/01/26 15:06:50
NME

Base Information

Drug NameARX-001822
Drug Alias NameA2aR checkpoint inhibitor (Adorx Therapeutics/University of Nottingham)A2aR antagonist (Adorx Therapeutics/University of Nottingham)ARX-001822
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor antagonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Nottingham
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A